Experimental drug from Emory could see immediate use in India COVID surge

Amid Humanitarian Crisis in India, Merck Announces Voluntary Licensing Agreements with Five Indian Generics Manufacturers to Accelerate and Expand Global Access to Molnupiravir, an Investigational Oral Therapeutic for the Treatment of COVID-19

Antios Therapeutics Raises $96 Million in a Series B Financing